Related Experiment Video
Updated: Jul 26, 2026

07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
Multiphasic anaphylaxis: an uncommon event in the emergency department
W J Brady1, S Luber, C T Carter
1Department of Emergency Medicine, University of Virginia School of Medicine, Charlottesville, USA. wb4z@galen.med.virginia.edu
Summary
Recurrent anaphylaxis symptoms after emergency department treatment are rare, occurring in only 3% of cases. This suggests selective outpatient management may be suitable for patients with severe anaphylaxis who respond well to initial therapy.
Area of Science:
- Emergency Medicine
- Allergy and Immunology
Background:
- Anaphylaxis is a severe allergic reaction requiring prompt emergency department (ED) evaluation and management.
- Understanding the rate of symptom recurrence is crucial for determining appropriate post-ED care strategies.
Purpose of the Study:
- To determine the incidence of clinically significant symptom recurrence in patients treated for anaphylaxis in the ED.
- To evaluate the safety and feasibility of outpatient management for select anaphylaxis patients.
Main Methods:
- A retrospective chart review was conducted on 67 patients diagnosed with anaphylaxis in an ED over a 4.5-year period.
- Patients met criteria for anaphylaxis involving at least two organ systems (cutaneous, respiratory, cardiovascular).
- Symptom recurrence was tracked for 7 days post-ED discharge, including hospital records and death registries.
Main Results:
- Of 67 anaphylaxis cases, 93% had immediate symptom resolution in the ED.
- Only 2 cases (3%) experienced symptom recurrence, both presenting solely as urticaria.
- No life-threatening recurrences or out-of-hospital deaths were identified in the study cohort.
Conclusions:
- Clinically significant anaphylaxis recurrence is uncommon (3%) and generally not life-threatening.
- Selective outpatient management may be a reasonable option for severe anaphylaxis cases with rapid and complete symptom resolution.
- Further research is needed to establish clear criteria for guiding outpatient disposition decisions in anaphylaxis management.
Related Concept Videos
Allergic Reactions
Overview
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...

